---
title: 'Author Correction: Neoadjuvant atezolizumab for resectable non-small cell
  lung cancer: an open-label, single-arm phase II trial'
date: '2023-10-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37816821/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231011181114&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...